Tachycardia as an undescribed adverse effect to the Comirnaty© vaccine (BNT162b2 Pfizer-BioNTech Covid-19 vaccine): Description of 3 cases with a history of SARS-CoV-2 disease.
作者信息
Marco García M Teresa, Torres Lana Álvaro, Anta Agudo M Berta, Rufino Delgado M de la Trinidad
机构信息
Gerencia de Atención Primaria de Tenerife, Servicio Canario de Salud, Santa Cruz de Tenerife, España.
Dirección General de Salud Pública, Servicio Canario de Salud, Santa Cruz de Tenerife, España.
出版信息
Enferm Infecc Microbiol Clin (Engl Ed). 2021 Mar 18;40(5):276-7. doi: 10.1016/j.eimc.2021.03.008.
Abstract
摘要
相似文献
1
Tachycardia as an undescribed adverse effect to the Comirnaty© vaccine (BNT162b2 Pfizer-BioNTech Covid-19 vaccine): Description of 3 cases with a history of SARS-CoV-2 disease.
Enferm Infecc Microbiol Clin (Engl Ed). 2021 Mar 18;40(5):276-7. doi: 10.1016/j.eimc.2021.03.008.
2
Tachycardia as an undescribed adverse effect to the Comirnaty© vaccine (BNT162b2 Pfizer-BioNTech Covid-19 vaccine): Description of 3 cases with a history of SARS-CoV-2 disease.心动过速作为Comirnaty©疫苗（辉瑞 - 生物科技公司的BNT162b2新冠疫苗）未描述的不良反应：3例有新冠病毒疾病史病例的描述
Enferm Infecc Microbiol Clin (Engl Ed). 2022 May;40(5):276-277. doi: 10.1016/j.eimce.2022.03.002. Epub 2022 Apr 26.
3
Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine-a case report.Status migrainosus：一种潜在的辉瑞/ BioNtech（BNT162b2）COVID-19 疫苗不良反应-病例报告。
Neurol Sci. 2022 Feb;43(2):767-770. doi: 10.1007/s10072-021-05741-x. Epub 2021 Nov 22.
4
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
5
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.免疫实践咨询委员会关于在 5-11 岁儿童中使用辉瑞-生物技术公司 COVID-19 疫苗的临时建议-美国，2021 年 11 月。
MMWR Morb Mortal Wkly Rep. 2021 Nov 12;70(45):1579-1583. doi: 10.15585/mmwr.mm7045e1.
6
Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [Comirnaty]).因 SARS-CoV-2 疫苗（辉瑞-生物科技 BNT162b2 信使 RNA COVID-19 疫苗[Comirnaty]）而引发的急性哮喘恶化。
Int J Infect Dis. 2022 Nov;124:187-189. doi: 10.1016/j.ijid.2022.09.019. Epub 2022 Sep 16.
7
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021.《16 岁及以上人群使用辉瑞-生物科技公司的 COVID-19 疫苗：免疫实践咨询委员会的建议——美国，2021 年 9 月》。
MMWR Morb Mortal Wkly Rep. 2021 Sep 24;70(38):1344-1348. doi: 10.15585/mmwr.mm7038e2.
8
The Effect of Third Dose of Pfizer/BioNTech and Moderna COVID-19 mRNA Vaccines on IgG Antibody Titers.辉瑞/生物科技公司和莫德纳新冠病毒mRNA疫苗第三剂对IgG抗体滴度的影响。
Cureus. 2023 Jul 11;15(7):e41696. doi: 10.7759/cureus.41696. eCollection 2023 Jul.
9
SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assays.辉瑞/生物新技术公司（BioNTech/Pfizer）的 Comirnaty（BNT162b2）接种一剂或两剂后针对 SARS-CoV-2 的中和抗体：动力学和与化学发光检测的比较。
Clin Chim Acta. 2021 Dec;523:446-453. doi: 10.1016/j.cca.2021.10.028. Epub 2021 Oct 28.
10
Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021.辉瑞-生物技术公司（Pfizer-BioNTech）疫苗 BNT162b2 对预防 12-17 岁青少年感染 SARS-CoV-2 的疫苗有效性的临时估计-亚利桑那州，2021 年 7 月至 12 月。
MMWR Morb Mortal Wkly Rep. 2021 Dec 31;70(5152):1761-1765. doi: 10.15585/mmwr.mm705152a2.
引用本文的文献
1
[Pharmacovigilance of vaccines against COVID-19 in community pharmacies. Results with the first dose].[社区药房中新冠疫苗的药物警戒。首剂接种结果]
Farm Comunitarios. 2023 Jan 2;15(1):22-40. doi: 10.33620/FC.2173-9218.(2023).04.
2
Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview.2019冠状病毒病疫苗的心血管并发症：概述
Cardiol Ther. 2022 Mar;11(1):13-21. doi: 10.1007/s40119-021-00248-0. Epub 2021 Nov 29.
本文引用的文献
1
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
Zotero 插件